Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Local vaginal immune recognition pathways encompass the complex network of pattern recognition receptors (PRRs), including Toll-like receptors (TLRs) and NOD-like receptors (NLRs), that monitor the cervicovaginal environment for pathogens (Wira et al., 2011, Nature Reviews Immunology). These pathways are primarily located on vaginal epithelial cells and resident immune cells, where they detect pathogen-associated molecular patterns (PAMPs) from bacteria, viruses, and fungi (Hickey et al., 2011, Journal of Reproductive Immunology). Upon activation, these pathways trigger the production of cytokines, chemokines, and antimicrobial peptides to initiate a local immune response (Ghosh et al., 2014, American Journal of Reproductive Immunology). While essential for defense against sexually transmitted infections (STIs) like HIV and HSV-2, dysregulation of these pathways can lead to chronic inflammation or increased vulnerability to infection (Anahtar et al., 2015, Immunity). Therapeutic strategies often focus on modulating these pathways using TLR agonists like imiquimod or probiotics to restore a healthy immune balance and prevent disease transmission (StatPearls, 2023). However, excessive activation can lead to mucosal inflammation, which may paradoxically increase the risk of HIV acquisition by recruiting target T-cells to the vaginal mucosa (Passmore et al., 2016, Journal of the International AIDS Society).
Modulation of pattern recognition receptors (PRRs) to enhance or regulate local innate and adaptive immune responses against pathogens.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Local vaginal immune recognition pathways.